Total Payments
$4,988
2022 Payments
$13.28
Companies
25
Transactions
139
Medicare Patients
2,185
Medicare Billing
$236,755
Payment Breakdown by Category
Food & Beverage$4,988 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,988 | 139 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $946.07 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $583.87 | 7 | $0 (2020) |
| Allergan, Inc. | $568.08 | 46 | $0 (2021) |
| Medtronic USA, Inc. | $536.70 | 9 | $0 (2019) |
| EMD Serono, Inc. | $324.69 | 3 | $0 (2019) |
| ABBVIE INC. | $309.12 | 23 | $0 (2022) |
| Biogen, Inc. | $279.08 | 3 | $0 (2017) |
| US WorldMeds, LLC | $241.91 | 8 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $136.83 | 2 | $0 (2018) |
| Boston Scientific Corporation | $128.14 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.28 | 1 | ABBVIE INC. ($13.28) |
| 2021 | $474.65 | 32 | AbbVie Inc. ($295.84) |
| 2020 | $395.88 | 15 | Avanir Pharmaceuticals, Inc. ($117.39) |
| 2019 | $1,263 | 32 | Novartis Pharmaceuticals Corporation ($345.90) |
| 2018 | $1,411 | 35 | Teva Pharmaceuticals USA, Inc. ($347.31) |
| 2017 | $1,430 | 24 | Medtronic USA, Inc. ($464.54) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: PRIMARY CARE | ||||||
| 07/27/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: Neuroscience | ||||||
| 07/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/24/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/08/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Central Nervous System | ||||||
| 06/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2021 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $21.76 | General |
| 05/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Neuromodulation | ||||||
| 04/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: PD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 16 | 789 | 1,006 | $325,660 | $90,462 |
| 2020 | 17 | 1,396 | 1,791 | $565,835 | $146,292 |
Total Patients
2,185
Total Services
2,797
Medicare Billing
$236,755
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 259 | 448 | $170,240 | $48,779 | 28.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 44 | 45 | $59,850 | $16,922 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 120 | 131 | $34,060 | $9,254 | 27.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 35 | 35 | $20,300 | $4,869 | 24.0% |
| 96138 | Psychological or neuropsychological test administration and scoring by technician, first 30 minutes | Office | 2021 | 103 | 104 | $14,560 | $3,239 | 22.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 22 | $11,220 | $3,237 | 28.8% |
| 96139 | Psychological or neuropsychological test administration and scoring by technician, additional 30 minutes | Office | 2021 | 59 | 65 | $9,100 | $2,256 | 24.8% |
| 82306 | Vitamin d-3 level | Office | 2021 | 13 | 14 | $1,400 | $414.40 | 29.6% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2021 | 14 | 14 | $770.00 | $237.16 | 30.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 14 | 14 | $770.00 | $235.20 | 30.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 15 | 15 | $750.00 | $226.20 | 30.2% |
| 82746 | Folic acid level, serum | Office | 2021 | 15 | 15 | $750.00 | $220.50 | 29.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 16 | 19 | $665.00 | $200.64 | 30.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 18 | 21 | $525.00 | $163.17 | 31.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 13 | 13 | $390.00 | $117.26 | 30.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 30 | 31 | $310.00 | $93.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 372 | 649 | $246,620 | $63,084 | 25.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 87 | 87 | $115,710 | $30,665 | 26.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 91 | 91 | $52,780 | $13,246 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 160 | 198 | $51,480 | $13,146 | 25.5% |
| 96138 | Psychological or neuropsychological test administration and scoring by technician, first 30 minutes | Office | 2020 | 181 | 187 | $26,180 | $6,749 | 25.8% |
| 96139 | Psychological or neuropsychological test administration and scoring by technician, additional 30 minutes | Office | 2020 | 119 | 176 | $24,640 | $6,355 | 25.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 40 | 41 | $20,910 | $5,752 | 27.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 18 | 18 | $13,140 | $2,976 | 22.7% |
| 82306 | Vitamin d-3 level | Office | 2020 | 31 | 31 | $3,100 | $915.83 | 29.5% |
About Dr. Erik Entin, M.D
Dr. Erik Entin, M.D is a Neurology healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861477820.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erik Entin, M.D has received a total of $4,988 in payments from pharmaceutical and medical device companies, with $13.28 received in 2022. These payments were reported across 139 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,988).
As a Medicare-enrolled provider, Entin has provided services to 2,185 Medicare beneficiaries, totaling 2,797 services with total Medicare billing of $236,755. Data is available for 2 years (2020–2021), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Plainview, NY
- Active Since 12/13/2005
- Last Updated 07/09/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1861477820
Products in Payments
- ACTIVA (Device) $536.70
- MAYZENT (Drug) $437.96
- AJOVY (Drug) $331.31
- COPAXONE (Drug) $329.77
- BOTOX (Biological) $278.14
- Rebif (Biological) $226.16
- UBRELVY (Drug) $217.17
- AUSTEDO (Drug) $186.94
- APOKYN (Drug) $150.00
- APTIOM (Drug) $136.83
- BOTOX THERAPEUTIC (Biological) $134.07
- VERCISE (Device) $128.14
- OCREVUS (Biological) $125.00
- NOURIANZ (Drug) $124.99
- NUPLAZID (Drug) $117.63
- NUEDEXTA (Drug) $117.39
- INBRIJA (Drug) $108.00
- ZINBRYTA (Biological) $106.37
- VRAYLAR (Drug) $99.58
- Mavenclad (Biological) $98.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Plainview
Dr. Stephen Newman, M.d, M.D
Neurology — Payments: $1.2M
Neurology $1.2M
Dr. Ira Turner, M.d, M.D
Neurology — Payments: $865,285
Neurology $865,285
Dr. John Kelemen, M.d, M.D
Neurology — Payments: $168,048
Neurology $168,048
Jennifer Ahmed
Neurology — Payments: $27,427
Neurology $27,427
Dr. Vandana Soni, M.d, M.D
Neurology — Payments: $2,106
Neurology $2,106
Dr. Michael Gruttadauria, Dc, Dacan, DC, DACAN
Neurology — Payments: $10.79
Neurology $10.79